NASDAQ:FONR - Fonar Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $24.95 +0.10 (+0.40 %) (As of 09/19/2018 01:37 PM ET)Previous Close$25.10Today's Range$24.95 - $25.1052-Week Range$21.10 - $33.90Volume321 shsAverage Volume28,625 shsMarket Capitalization$157.50 millionP/E Ratio7.85Dividend YieldN/ABeta2.18 Company ProfileDiscussionChartEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Fonar Corporation, together with its subsidiaries, engages in the design, manufacture, sale, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, and other medical conditions and injuries. It operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. The company offers Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. It markets its scanners to private diagnostic imaging centers and hospitals. The company also provides management services, administrative services, billing and collection services, office space, equipment, repair, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. Fonar Corporation owns and operates 4 diagnostic imaging facilities in Florida; and manages 26 MRI scanning facilities, including 17 facilities located in New York and 7 facilities located in Florida. Fonar Corporation was founded in 1978 and is based in Melville, New York. Receive FONR News and Ratings via Email Sign-up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical SymbolNASDAQ:FONR CUSIPN/A Webwww.fonar.com Phone631-694-2929 Debt Debt-to-Equity RatioN/A Current Ratio4.96 Quick Ratio4.82 Price-To-Earnings Trailing P/E Ratio7.85 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$81.52 million Price / Sales1.93 Cash Flow$3.7183 per share Price / Cash6.71 Book Value$13.37 per share Price / Book1.87 Profitability EPS (Most Recent Fiscal Year)N/A Net Income$19.90 million Net Margins24.41% Return on Equity22.90% Return on Assets19.63% Miscellaneous Employees500 Outstanding Shares6,290,000Market Cap$157.50 million Fonar (NASDAQ:FONR) Frequently Asked Questions What is Fonar's stock symbol? Fonar trades on the NASDAQ under the ticker symbol "FONR." How were Fonar's earnings last quarter? Fonar Co. (NASDAQ:FONR) announced its earnings results on Thursday, May, 10th. The medical equipment provider reported $0.51 earnings per share for the quarter. The medical equipment provider earned $20.98 million during the quarter. Fonar had a return on equity of 22.90% and a net margin of 24.41%. View Fonar's Earnings History. When is Fonar's next earnings date? Fonar is scheduled to release their next quarterly earnings announcement on Thursday, November, 8th 2018. View Earnings Estimates for Fonar. Who are some of Fonar's key competitors? Some companies that are related to Fonar include electroCore (ECOR), Cutera (CUTR), BioLife Solutions (BLFS), Vision Sciences (CGNT), Rockwell Medical (RMTI), Semler Scientific (SMLR), Helius Medical Technologies (HSDT), Second Sight Medical Products (EYES), Zynex (ZYXI), Viveve Medical (VIVE), Edap Tms (EDAP), IRIDEX (IRIX), BioSig Technologies (BSGM), Stereotaxis (STXS) and Soleno Therapeutics (SLNO). Who are Fonar's key executives? Fonar's management team includes the folowing people: Dr. Raymond V. Damadian, Chairman, Principal Financial Officer & Treasurer (Age 82)Mr. Timothy R. Damadian, CEO & Pres (Age 54)Mr. Luciano B. Bonanni, COO & Exec. VP (Age 63)Ms. Claudette J. V. Chan, Sec. & Director (Age 80)Mr. Daniel Culver, Director of Communications Has Fonar been receiving favorable news coverage? News stories about FONR stock have been trending somewhat positive on Wednesday, according to Accern Sentiment Analysis. The research firm ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Fonar earned a coverage optimism score of 0.18 on Accern's scale. They also assigned news coverage about the medical equipment provider an impact score of 46.57 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next several days. View Recent Headlines for Fonar. Who are Fonar's major shareholders? Fonar's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (7.09%), BlackRock Inc. (5.54%), LSV Asset Management (4.86%), Dimensional Fund Advisors LP (3.96%), Northern Trust Corp (1.51%) and Bowling Portfolio Management LLC (0.98%). Company insiders that own Fonar stock include Raymond V Damadian and Robert J Janoff. View Institutional Ownership Trends for Fonar. Which institutional investors are selling Fonar stock? FONR stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Bowling Portfolio Management LLC, Northern Trust Corp, Public Employees Retirement System of Ohio and Renaissance Technologies LLC. Company insiders that have sold Fonar company stock in the last year include Raymond V Damadian and Robert J Janoff. View Insider Buying and Selling for Fonar. Which institutional investors are buying Fonar stock? FONR stock was acquired by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, BlackRock Inc., LSV Asset Management, Hikari Tsushin Inc., Stanley Laman Group Ltd., Spark Investment Management LLC, Mackay Shields LLC and Bank of New York Mellon Corp. View Insider Buying and Selling for Fonar. How do I buy shares of Fonar? Shares of FONR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Fonar's stock price today? One share of FONR stock can currently be purchased for approximately $24.95. How big of a company is Fonar? Fonar has a market capitalization of $157.50 million and generates $81.52 million in revenue each year. Fonar employs 500 workers across the globe. How can I contact Fonar? Fonar's mailing address is 110 Marcus Drive, Melville NY, 11747. The medical equipment provider can be reached via phone at 631-694-2929 or via email at [email protected] MarketBeat Community Rating for Fonar (NASDAQ FONR)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 76 (Vote Outperform)Underperform Votes: 82 (Vote Underperform)Total Votes: 158MarketBeat's community ratings are surveys of what our community members think about Fonar and other stocks. Vote "Outperform" if you believe FONR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FONR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 9/19/2018 by MarketBeat.com StaffFeatured Article: Asset Allocation Models, Which is Right For You?